These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 16291487)
1. Availability of medical abortion pills and the role of chemists: a study from Bihar and Jharkhand, India. Ganatra B; Manning V; Pallipamulla SP Reprod Health Matters; 2005 Nov; 13(26):65-74. PubMed ID: 16291487 [TBL] [Abstract][Full Text] [Related]
2. Availability and acceptability of medical abortion in Nepal: health care providers' perspectives. Tamang A; Tamang J Reprod Health Matters; 2005 Nov; 13(26):110-9. PubMed ID: 16291492 [TBL] [Abstract][Full Text] [Related]
3. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients]. Faucher P; Baunot N; Madelenat P Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206 [TBL] [Abstract][Full Text] [Related]
4. The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion. Creinin MD; Shore E; Balasubramanian S; Harwood B Contraception; 2005 Jan; 71(1):26-30. PubMed ID: 15639068 [TBL] [Abstract][Full Text] [Related]
5. Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services. Gomperts RJ; Jelinska K; Davies S; Gemzell-Danielsson K; Kleiverda G BJOG; 2008 Aug; 115(9):1171-5; discussion 1175-8. PubMed ID: 18637010 [TBL] [Abstract][Full Text] [Related]
6. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial. Chawdhary R; Rana A; Pradhan N J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552 [TBL] [Abstract][Full Text] [Related]
7. Study supports the introduction of early medical abortion in Turkey. Akin A; Kocoglu GO; Akin L Reprod Health Matters; 2005 Nov; 13(26):101-9. PubMed ID: 16291491 [TBL] [Abstract][Full Text] [Related]
8. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone. Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414 [TBL] [Abstract][Full Text] [Related]
9. Are two doses of misoprostol after mifepristone for early abortion better than one? Coyaji K; Krishna U; Ambardekar S; Bracken H; Raote V; Mandlekar A; Winikoff B BJOG; 2007 Mar; 114(3):271-8. PubMed ID: 17217359 [TBL] [Abstract][Full Text] [Related]
10. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management. Gemzell-Danielsson K; Lalitkumar S Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097 [TBL] [Abstract][Full Text] [Related]
11. Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center. Mundle S; Elul B; Anand A; Kalyanwala S; Ughade S Contraception; 2007 Jul; 76(1):66-70. PubMed ID: 17586140 [TBL] [Abstract][Full Text] [Related]
12. Availability of mifepristone and misoprostol in Oregon pharmacies: A comparison by rural and urban status. Mnuk R; Schrote K; Garg B; Doshi U; Rodriguez MI Contraception; 2024 Sep; 137():110491. PubMed ID: 38763275 [TBL] [Abstract][Full Text] [Related]
13. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial. Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204 [TBL] [Abstract][Full Text] [Related]
14. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion. Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851 [TBL] [Abstract][Full Text] [Related]
15. Support for provision of early medical abortion by mid-level providers in Bihar and Jharkhand, India. Patel L; Bennett TA; Halpern CT; Johnston HB; Suchindran CM Reprod Health Matters; 2009 May; 17(33):70-9. PubMed ID: 19523584 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion. Kapp N; Borgatta L; Ellis SC; Stubblefield P Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039 [TBL] [Abstract][Full Text] [Related]
17. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases. Rose SB; Shand C; Simmons A Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051 [TBL] [Abstract][Full Text] [Related]
18. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Creinin MD; Schreiber CA; Bednarek P; Lintu H; Wagner MS; Meyn LA; Obstet Gynecol; 2007 Apr; 109(4):885-94. PubMed ID: 17400850 [TBL] [Abstract][Full Text] [Related]
19. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases. Goh SE; Thong KJ Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037 [TBL] [Abstract][Full Text] [Related]
20. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial. von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A; BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]